UNII 22ADO53M6F

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Unique Ingredient Identifier 22ADO53M6F is listed as a ingredient substance
Unii22ADO53M6F
Preferred Substance NameSODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Rn7558-79-4
Ec231-448-7
NcitC66546
Rxcui314838
Pubchem24203
Molecular Formula2Na.HO4P
InchikeyBNIILDVGGAEEIG-UHFFFAOYSA-L
Smiles[Na+].[Na+].OP([O-])([O-])=O
Unii TypeINGREDIENT SUBSTANCE
RN7558-79-4
EC231-448-7
NCITC66546
RXCUI314838
PUBCHEM24203
MF2Na.HO4P
INCHI KEYBNIILDVGGAEEIG-UHFFFAOYSA-L
SMILES[Na+].[Na+].OP([O-])([O-])=O

Alternate Names

Dosage Forms

UNII 22ADO53M6F SODIUM PHOSPHATE, DIBASIC, ANHYDROUS is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALFILM0.35 MG
IM - IVINJECTABLE1.75 %
IM - IVINJECTION13.92 %
IM - IVPOWDER, FOR INJECTION SOLUTION13.92 %
INTRA-ARTERIALSUSPENSION, INJECTION1.42 mg/1mL
INTRA-ARTICULARINJECTABLE0.71 %
INTRALESIONALINJECTABLE0.71 %
INTRALESIONALSUSPENSION, INJECTION1.42 mg/1mL
INTRAMUSCULARINJECTABLE0.71 %
INTRAMUSCULARINJECTABLE0.7 mg/1mL
INTRAMUSCULARINJECTION27.8 %
INTRAMUSCULARINJECTION, SUSPENSION, EXTENDED RELEASE0.2 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION NA
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.03 %
INTRAMUSCULARSUSPENSION, INJECTION1.42 mg/1mL
INTRAOCULARINSERT2.88 %
INTRA-SYNOVIALSUSPENSION, INJECTION1.42 mg/1mL
INTRAVENOUSINJECTABLE0.24 %
INTRAVENOUSINJECTION40 MG/VIAL
INTRAVENOUSINJECTION27.8 %
INTRAVENOUSINJECTION, EMULSION2.8 MG/ML
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION3.25 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED1.5 %
INTRAVENOUSSOLUTION0.048 %
INTRAVENOUSSOLUTION, INJECTION0.01 %
INTRAVESICALSOLUTION, INJECTION3.83 %
IV(INFUSION)INFUSION0.01 %
IV(INFUSION)INJECTABLE0.012 %
IV(INFUSION)INJECTION4 %
IV(INFUSION)LIQUID0.476 MG/ML
IV(INFUSION)POWDER, FOR INJECTION SOLUTION13.92 %
IV(INFUSION)SOLUTION, INJECTION0.012 %
NASALSOLUTION0.5 %
NASALSPRAY0.011 %
NASALSPRAY, METERED887.76 MCG/SPRAY
NASALSPRAY, METERED0.5 %
OPHTHALMICSOLUTION5 MG/1ML
OPHTHALMICSOLUTION1.28 %
OPHTHALMICSOLUTION0.47 %W/V
OPHTHALMICSOLUTION, DROPS5 MG/ML
OPHTHALMICSOLUTION, DROPS5 mg/1mL
OPHTHALMICSOLUTION, DROPS1.4 %
OPHTHALMICSOLUTION, DROPS0.5 %W/V
OPHTHALMICSUSPENSION0.25 %
ORALCAPSULE300 MG
ORALCAPSULE, DELAYED RELEASE4.8 MG
ORALCAPSULE, ENTERIC COATED PELLETS2 MG
ORALFILM, SOLUBLE0.054 MG
ORALSOLUTION300 MG
ORALSOLUTION, SYRUP17.5 MG/1ML
ORALSUSPENSION33 MG/5ML
ORALSUSPENSION6.59 mg/1mL
ORALSYRUP3.5 MG/1ML
ORALTABLET96 MG
ORALTABLET, EXTENDED RELEASE105 MG
ORALTABLET, FILM COATED0.015 MG
ORALTABLET, SUSTAINED ACTION110 MG
ORALTABLET, UNCOATED, LOZENGE31 MG
ORALTABLET, UNCOATED, TROCHE28 MG
SOFT TISSUESUSPENSION, INJECTION1.42 mg/1mL
SUBCUTANEOUSINJECTABLE0.1 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.03 %
SUBCUTANEOUSSOLUTION, INJECTION0.012 %
SUBLINGUALFILM4.066 mg
TOPICALEMULSION, AEROSOL FOAM0.09 %W/W
TOPICALEMULSION, CREAM0.36 %W/W
TOPICALGEL NA
TOPICALLOTION NA
TOPICALOINTMENT NA
TOPICALSOLUTION0.47 %W/V
TOPICALSOLUTION, DROPS0.45 %W/V
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.09 %

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.